ARTICLE | Company News
BioInvent, ThromboGenics vascular deal
September 28, 2004 7:00 AM UTC
BioInvent (SSE:BINV) and ThromboGenics (Dublin, Ireland) partnered to co-develop antibody therapeutics to treat vascular diseases. BINV will contribute its n-CoDeR antibody library, discovery and immu...